当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 202008
编号:13824696
布地奈德联合异丙托溴铵雾化治疗小儿呼吸道感染所致慢性咳嗽疗效观察
http://www.100md.com 2020年8月1日 《特别健康·下半月》 202008
     【摘要】目的:观察布地奈德联合异丙托溴铵雾化治疗小儿呼吸道感染所致慢性咳嗽疗效。方法:在本院2018年10月至2019年10月收治的呼吸道感染所致慢性咳嗽患儿中抽取100例,随机划分为对照组与观察组各50例,对照组患儿予以布地奈德治疗,观察组患儿予以布地奈德联合异丙托溴铵雾化治疗。对比两组患儿临床治疗效果。结果:观察组患儿临床治疗总有效率(98.00%),显著高于对照组患儿的(92.00%),差异具备统计学意义(P<0.05)。结论:布地奈德联合异丙托溴铵雾化治疗小儿呼吸道感染所致慢性咳嗽疗效,显著高于单一运用布地奈德治疗所产生的疗效,值得在临床中进行推广。

    【关键词】布地奈德;联合;异丙托溴铵雾化;呼吸道感染;慢性咳嗽;疗效;观察

    [Abstract] Objective:To observe the therapeutic effect of budesonide combined with ipratropium bromide in the treatment of chronic cough caused by respiratory infection in children. Methods: A total of 100 children with chronic cough due to respiratory tract infection admitted to our hospital from October 2018 to October 2019 were randomly divided into a control group and an observation group of 50 cases. The children in the observation group were treated with budesonide combined with ipratropium bromide. Compare the clinical treatment effect of the two groups of children. Results: The total effective rate of clinical treatment in the observation group (98.00%) was significantly higher than that in the control group (92.00%) ......

您现在查看是摘要页,全文长 4867 字符